2024-03-28 |
2024-03-18 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
800
+0.8%
0.61
488
USD
|
800
+0.8%
|
0.61
|
488
USD
|
|
2024-03-20 |
2024-03-18 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
19,044
+0.1%
0.60
11,398
USD
|
19,044
+0.1%
|
0.60
|
11,398
USD
|
|
2024-03-28 |
2024-03-15 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
1,200
+1.2%
0.56
672
USD
|
1,200
+1.2%
|
0.56
|
672
USD
|
|
2024-03-18 |
2024-03-15 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
537,500
+1.8%
0.59
314,545
USD
|
537,500
+1.8%
|
0.59
|
314,545
USD
|
|
2024-03-28 |
2024-03-14 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
2,000
+2.0%
0.53
1,061
USD
|
2,000
+2.0%
|
0.53
|
1,061
USD
|
|
2024-03-18 |
2024-03-14 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
648,372
+2.2%
0.54
351,677
USD
|
648,372
+2.2%
|
0.54
|
351,677
USD
|
|
2024-03-28 |
2024-03-13 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
3,200
+3.3%
0.58
1,868
USD
|
3,200
+3.3%
|
0.58
|
1,868
USD
|
|
2024-03-28 |
2024-03-12 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
1,200
+1.2%
0.61
735
USD
|
1,200
+1.2%
|
0.61
|
735
USD
|
|
2024-03-28 |
2024-03-11 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
1,200
+1.3%
0.65
785
USD
|
1,200
+1.3%
|
0.65
|
785
USD
|
|
2024-03-28 |
2024-03-08 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
4,800
+5.3%
0.66
3,187
USD
|
4,800
+5.3%
|
0.66
|
3,187
USD
|
|
2024-03-28 |
2024-02-07 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
2,400
+2.7%
0.66
1,575
USD
|
2,400
+2.7%
|
0.66
|
1,575
USD
|
|
2024-03-28 |
2024-02-06 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
800
+0.9%
0.65
520
USD
|
800
+0.9%
|
0.65
|
520
USD
|
|
2024-03-28 |
2024-01-17 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
800
+0.9%
0.69
552
USD
|
800
+0.9%
|
0.69
|
552
USD
|
|
2023-09-26 |
2023-09-25 |
S
Sale
|
Brunn Carsten
President and CEO
Executive Director
|
2,932
-0.4%
1.06
3,108
USD
|
2,932
-0.4%
|
1.06
|
3,108
USD
|
|
2023-09-26 |
2023-09-25 |
S
Sale
|
TRABER PETER G
Chief Medical Officer
Officer
|
705
-0.2%
1.06
747
USD
|
705
-0.2%
|
1.06
|
747
USD
|
|
2023-01-06 |
2023-01-05 |
S
Sale
|
Johnston Lloyd P.
Chief Operations Officer
Officer
|
20
-0.0%
1.11
22
USD
|
20
-0.0%
|
1.11
|
22
USD
|
|
2023-01-06 |
2023-01-05 |
S
Sale
|
Johnston Lloyd P.
Chief Operations Officer
Officer
|
3,372
-1.3%
1.13
3,808
USD
|
3,372
-1.3%
|
1.13
|
3,808
USD
|
|
2023-01-06 |
2023-01-05 |
S
Sale
|
Brunn Carsten
President and CEO
Executive Director
|
77
-0.0%
1.12
86
USD
|
77
-0.0%
|
1.12
|
86
USD
|
|
2023-01-06 |
2023-01-05 |
S
Sale
|
Brunn Carsten
President and CEO
Executive Director
|
13,396
-1.7%
1.13
15,128
USD
|
13,396
-1.7%
|
1.13
|
15,128
USD
|
|
2023-01-06 |
2023-01-05 |
S
Sale
|
Kishimoto Takashi Kei
Chief Scientific Officer
Officer
|
20
-0.0%
1.11
22
USD
|
20
-0.0%
|
1.11
|
22
USD
|
|
2023-01-06 |
2023-01-05 |
S
Sale
|
Kishimoto Takashi Kei
Chief Scientific Officer
Officer
|
3,372
-0.9%
1.13
3,808
USD
|
3,372
-0.9%
|
1.13
|
3,808
USD
|
|
2023-01-06 |
2023-01-05 |
S
Sale
|
TRABER PETER G
Chief Medical Officer
Officer
|
20
-0.0%
1.11
22
USD
|
20
-0.0%
|
1.11
|
22
USD
|
|
2023-01-06 |
2023-01-05 |
S
Sale
|
TRABER PETER G
Chief Medical Officer
Officer
|
3,445
-0.8%
1.13
3,890
USD
|
3,445
-0.8%
|
1.13
|
3,890
USD
|
|
2023-01-06 |
2023-01-04 |
S
Sale
|
Johnston Lloyd P.
Chief Operations Officer
Officer
|
11
-0.0%
1.14
13
USD
|
11
-0.0%
|
1.14
|
13
USD
|
|
2023-01-06 |
2023-01-04 |
S
Sale
|
Johnston Lloyd P.
Chief Operations Officer
Officer
|
6,381
-2.3%
1.13
7,234
USD
|
6,381
-2.3%
|
1.13
|
7,234
USD
|
|
2023-01-06 |
2023-01-04 |
S
Sale
|
Brunn Carsten
President and CEO
Executive Director
|
48
-0.0%
1.15
55
USD
|
48
-0.0%
|
1.15
|
55
USD
|
|
2023-01-06 |
2023-01-04 |
S
Sale
|
Brunn Carsten
President and CEO
Executive Director
|
27,549
-3.3%
1.13
31,232
USD
|
27,549
-3.3%
|
1.13
|
31,232
USD
|
|
2023-01-06 |
2023-01-04 |
S
Sale
|
Kishimoto Takashi Kei
Chief Scientific Officer
Officer
|
11
-0.0%
1.15
13
USD
|
11
-0.0%
|
1.15
|
13
USD
|
|
2023-01-06 |
2023-01-04 |
S
Sale
|
Kishimoto Takashi Kei
Chief Scientific Officer
Officer
|
6,381
-1.7%
1.13
7,234
USD
|
6,381
-1.7%
|
1.13
|
7,234
USD
|
|
2023-01-06 |
2023-01-04 |
S
Sale
|
TRABER PETER G
Chief Medical Officer
Officer
|
15
-0.0%
1.14
17
USD
|
15
-0.0%
|
1.14
|
17
USD
|
|
2023-01-06 |
2023-01-04 |
S
Sale
|
TRABER PETER G
Chief Medical Officer
Officer
|
8,164
-1.8%
1.13
9,256
USD
|
8,164
-1.8%
|
1.13
|
9,256
USD
|
|
2022-12-07 |
2022-12-05 |
S
Sale
|
Brunn Carsten
President and CEO
Executive Director
|
4,522
-0.8%
1.33
6,014
USD
|
4,522
-0.8%
|
1.33
|
6,014
USD
|
|
2022-09-06 |
2022-09-02 |
S
Sale
|
Brunn Carsten
President and CEO
Executive Director
|
4,768
-0.9%
1.85
8,810
USD
|
4,768
-0.9%
|
1.85
|
8,810
USD
|
|
2022-06-15 |
2022-06-13 |
B
Purchase
|
COX CARRIE SMITH
Non-Executive Director
|
130,000
+156.9%
1.15
149,799
USD
|
130,000
+156.9%
|
1.15
|
149,799
USD
|
|
2022-05-11 |
2022-05-09 |
B
Purchase
|
BARABE TIMOTHY C
Non-Executive Director
|
50,000
+25.0%
0.77
38,720
USD
|
50,000
+25.0%
|
0.77
|
38,720
USD
|
|
2022-04-13 |
2022-04-11 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
6,681,600
0.00
0
USD
|
6,681,600
|
0.00
|
0
USD
|
|
2022-03-03 |
2022-03-02 |
S
Sale
|
Brunn Carsten
President and CEO
Executive Director
|
5,443
-1.0%
1.81
9,863
USD
|
5,443
-1.0%
|
1.81
|
9,863
USD
|
|
2022-01-07 |
2022-01-05 |
S
Sale
|
Johnston Lloyd P.
Chief Operations Officer
Officer
|
3,416
-1.9%
3.09
10,541
USD
|
3,416
-1.9%
|
3.09
|
10,541
USD
|
|
2022-01-07 |
2022-01-05 |
S
Sale
|
Brunn Carsten
President and CEO
Executive Director
|
13,597
-2.6%
3.09
41,959
USD
|
13,597
-2.6%
|
3.09
|
41,959
USD
|
|
2022-01-07 |
2022-01-05 |
S
Sale
|
TRABER PETER G
Chief Medical Officer
Officer
|
3,226
-1.3%
3.09
9,955
USD
|
3,226
-1.3%
|
3.09
|
9,955
USD
|
|
2022-01-07 |
2022-01-05 |
S
Sale
|
Kishimoto Takashi Kei
Chief Scientific Officer
Officer
|
3,416
-1.3%
3.09
10,541
USD
|
3,416
-1.3%
|
3.09
|
10,541
USD
|
|
2021-12-17 |
2021-12-15 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
211,190
+0.9%
2.99
631,099
USD
|
211,190
+0.9%
|
2.99
|
631,099
USD
|
|
2021-12-13 |
2021-12-13 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
14,592
+0.1%
2.98
43,491
USD
|
14,592
+0.1%
|
2.98
|
43,491
USD
|
|
2021-12-14 |
2021-12-10 |
S
Sale
|
TRABER PETER G
Chief Medical Officer
Officer
|
4,083
-2.4%
2.99
12,196
USD
|
4,083
-2.4%
|
2.99
|
12,196
USD
|
|
2021-12-14 |
2021-12-10 |
S
Sale
|
Kishimoto Takashi Kei
Chief Scientific Officer
Officer
|
4,370
-2.1%
2.99
13,053
USD
|
4,370
-2.1%
|
2.99
|
13,053
USD
|
|
2021-12-14 |
2021-12-10 |
S
Sale
|
Johnston Lloyd P.
Chief Operations Officer
Officer
|
4,370
-3.9%
2.99
13,053
USD
|
4,370
-3.9%
|
2.99
|
13,053
USD
|
|
2021-12-14 |
2021-12-10 |
S
Sale
|
Brunn Carsten
President and CEO
Executive Director
|
17,196
-5.3%
2.99
51,363
USD
|
17,196
-5.3%
|
2.99
|
51,363
USD
|
|
2021-12-13 |
2021-12-10 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
58,681
+0.3%
2.99
175,439
USD
|
58,681
+0.3%
|
2.99
|
175,439
USD
|
|
2021-12-13 |
2021-12-09 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
3,748,000
+19.6%
3.06
11,468,880
USD
|
3,748,000
+19.6%
|
3.06
|
11,468,880
USD
|
|
2021-12-06 |
2021-12-03 |
B
Purchase
|
COX CARRIE SMITH
Non-Executive Director
|
17,200
+26.2%
2.95
50,664
USD
|
17,200
+26.2%
|
2.95
|
50,664
USD
|
|
2021-12-06 |
2021-12-02 |
B
Purchase
|
DeSilva Nishan M
Non-Executive Director
|
7,000
+inf%
2.96
20,723
USD
|
7,000
+inf%
|
2.96
|
20,723
USD
|
|
2021-12-06 |
2021-12-02 |
B
Purchase
|
Tan Kevin
Chief Financial Officer
Officer
|
5,000
+inf%
3.03
15,127
USD
|
5,000
+inf%
|
3.03
|
15,127
USD
|
|
2021-12-03 |
2021-12-02 |
S
Sale
|
Brunn Carsten
President and CEO
Executive Director
|
4,746
-1.6%
2.96
14,065
USD
|
4,746
-1.6%
|
2.96
|
14,065
USD
|
|
2021-10-15 |
2021-10-13 |
S
Sale
|
Kishimoto Takashi Kei
Chief Scientific Officer
Officer
|
3,892
-2.0%
4.39
17,086
USD
|
3,892
-2.0%
|
4.39
|
17,086
USD
|
|
2021-10-15 |
2021-10-13 |
S
Sale
|
Johnston Lloyd P.
Chief Operations Officer
Officer
|
3,892
-3.8%
4.39
17,086
USD
|
3,892
-3.8%
|
4.39
|
17,086
USD
|
|
2021-10-15 |
2021-10-13 |
S
Sale
|
Brunn Carsten
President and CEO
Executive Director
|
15,313
-5.2%
4.39
67,224
USD
|
15,313
-5.2%
|
4.39
|
67,224
USD
|
|
2021-10-15 |
2021-10-13 |
S
Sale
|
TRABER PETER G
Chief Medical Officer
Officer
|
3,636
-2.3%
4.39
15,962
USD
|
3,636
-2.3%
|
4.39
|
15,962
USD
|
|
2021-05-26 |
2021-05-26 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
926,170
+5.1%
4.00
3,705,699
USD
|
926,170
+5.1%
|
4.00
|
3,705,699
USD
|
|
2021-05-26 |
2021-05-25 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
383,830
+2.2%
3.55
1,362,098
USD
|
383,830
+2.2%
|
3.55
|
1,362,098
USD
|
|
2021-05-26 |
2021-05-24 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
590,000
+3.4%
3.38
1,992,076
USD
|
590,000
+3.4%
|
3.38
|
1,992,076
USD
|
|
2021-05-25 |
2021-05-21 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
2,773,479
+19.2%
3.19
8,847,398
USD
|
2,773,479
+19.2%
|
3.19
|
8,847,398
USD
|
|
2021-03-30 |
2021-03-26 |
B
Purchase
|
BARABE TIMOTHY C
Non-Executive Director
|
10,000
+5.8%
4.10
41,000
USD
|
10,000
+5.8%
|
4.10
|
41,000
USD
|
|
2021-03-19 |
2021-03-18 |
B
Purchase
|
TRABER PETER G
Chief Medical Officer
Officer
|
10,000
+11.4%
4.50
45,000
USD
|
10,000
+11.4%
|
4.50
|
45,000
USD
|
|
2021-03-19 |
2021-03-17 |
B
Purchase
|
TRABER PETER G
Chief Medical Officer
Officer
|
10,000
+12.8%
4.53
45,295
USD
|
10,000
+12.8%
|
4.53
|
45,295
USD
|
|
2021-03-19 |
2021-03-17 |
S
Sale
|
Johnston Lloyd P.
COO and SVP, R&D
Officer
|
15,128
-14.7%
4.45
67,312
USD
|
15,128
-14.7%
|
4.45
|
67,312
USD
|
|
2021-03-03 |
2021-03-02 |
S
Sale
|
Brunn Carsten
President and CEO
Executive Director
|
5,461
-2.5%
4.26
23,257
USD
|
5,461
-2.5%
|
4.26
|
23,257
USD
|
|
2020-12-16 |
2020-12-14 |
B
Purchase
|
TRABER PETER G
Chief Medical Officer
Officer
|
40,000
+inf%
3.24
129,424
USD
|
40,000
+inf%
|
3.24
|
129,424
USD
|
|
2020-12-03 |
2020-12-02 |
S
Sale
|
Brunn Carsten
President and CEO
Executive Director
|
3,323
-3.2%
3.35
11,134
USD
|
3,323
-3.2%
|
3.35
|
11,134
USD
|
|
2020-10-23 |
2020-10-23 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
994,488
+7.4%
2.71
2,699,737
USD
|
994,488
+7.4%
|
2.71
|
2,699,737
USD
|
|
2020-10-23 |
2020-10-22 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
1,770,204
+15.1%
2.63
4,656,699
USD
|
1,770,204
+15.1%
|
2.63
|
4,656,699
USD
|
|
2020-10-23 |
2020-10-21 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
880,000
+8.1%
2.50
2,199,472
USD
|
880,000
+8.1%
|
2.50
|
2,199,472
USD
|
|
2020-10-20 |
2020-10-20 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
910,000
+9.2%
2.21
2,013,193
USD
|
910,000
+9.2%
|
2.21
|
2,013,193
USD
|
|
2020-10-20 |
2020-10-19 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
759,500
+8.3%
2.36
1,795,002
USD
|
759,500
+8.3%
|
2.36
|
1,795,002
USD
|
|
2020-10-20 |
2020-10-16 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
218,196
+2.4%
2.42
528,034
USD
|
218,196
+2.4%
|
2.42
|
528,034
USD
|
|
2020-10-14 |
2020-10-09 |
B
Purchase
|
SPRINGER TIMOTHY A
Non-Executive Director
Large shareholder
|
276,703
+3.2%
2.00
552,465
USD
|
276,703
+3.2%
|
2.00
|
552,465
USD
|
|